AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 6628802
Drug: Khellin treatment
RxNorm normalized name: khellin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Khellin treatment
Trial: 29360560
Drug: Lidocaine dual-responsive
RxNorm normalized name: Tums Dual Action
DrugBank: Alginic acid (DB13518)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lidocaine dual-responsive in situ gel (2% lidocaine)
Trial: 27160246
Drug: icosabutate 600
RxNorm normalized name: Ethyl icosapentate
DrugBank: Icosapent ethyl (DB08887)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: icosabutate 600 mg once daily
Trial: 24996489
Drug: Morning administration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morning administration of controlled-release simvastatin 20 mg
Trial: 24996489
Drug: Evening administration
RxNorm normalized name: Evenity
DrugBank: Romosozumab (DB11866)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Evening administration of immediate-release simvastatin 20 mg
Trial: 22913681
Drug: Eltrombopag (75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Eltrombopag (75 mg daily for 14 days)
Trial: 16316352
Drug: Amino acid
RxNorm normalized name: Amino Acid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amino acid (AA) infusion
Trial: 9202909
Drug: Nasal midazolam
RxNorm normalized name: midazolam Nasal Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nasal midazolam (0.2 mg kg‐1, 5 mg ml‐1)
Trial: 9202909
Drug: Rectal midazolam
RxNorm normalized name: Midazolam
DrugBank: Midazolam (DB00683)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Rectal midazolam (0.3 mg kg‐1 in 5 mL saline)
Trial: 7962441
Drug: Progesterone (1.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Progesterone (1.0 micrograms/ml)
Trial: 24786217
Drug: Internal cardioverter
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Internal cardioverter defibrillator-only therapy
Trial: 23715050
Drug: LCP‐Tacro once-daily
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LCP‐Tacro once-daily
Trial: 24493215
Drug: Prograf twice-daily
RxNorm normalized name: clindamycin
DrugBank: Clindamycin (DB01190)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Prograf twice-daily
Trial: 20443101
Drug: Pegylated interferon
RxNorm normalized name: Pegylated interferon alfa-2a
DrugBank: Peginterferon alfa-2a (DB00008)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Pegylated interferon alfa 2b (1.5 microg/kg/week) with ribavirin (12-15 mg/kg/day; group B)
Trial: 18164145
Drug: Enhanced Services
RxNorm normalized name: SYRINGE SERVICES
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enhanced Services (nurse-delivered manual-guided behavioral drug and HIV risk reduction counseling and abstinence-contingent take-home buprenorphine)
Trial: 18164145
Drug: Standard Services
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard Services (physician administered advice and support, and weekly, non-contingent medication pick-up)
Trial: 16192247
Drug: Viral load
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Viral load > or =100,000 copies/mL
Trial: 12645830
Drug: Salmeterol/fluticasone combination
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Salmeterol/fluticasone combination (SFC) 50/100 microg twice daily
Trial: 12645830
Drug: Fluticasone propionate
RxNorm normalized name: Fluticasone Propionate
DrugBank: Fluticasone propionate (DB00588)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Fluticasone propionate (FP) 100 microg twice daily plus oral montelukast (M) 10 mg once daily
Trial: 12645830
Drug: Fluticasone propionate
RxNorm normalized name: Fluticasone Propionate
DrugBank: Fluticasone propionate (DB00588)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Fluticasone propionate (FP) plus oral montelukast (M)
Trial: 10665126
Drug: Intravenous/oral trovafloxacin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous/oral trovafloxacin (300 mg i.v. alatrofloxacin switching to 200 mg oral trovafloxacin)
Trial: 10665126
Drug: Intravenous imipenem/cilastatin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous imipenem/cilastatin switching to oral amoxycillin/clavulanic acid (1 g i.v. imipenem/cilastatin switching to 625 mg oral amoxycillin/clavulanic acid)
Trial: 20340049
Drug: Short-stay intensive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Short-stay intensive care treatment (SSIC, 8 h of intensive care stay)
Trial: 20340049
Drug: Control treatment
RxNorm normalized name: SALICYLIC ACID 190 mg in 1 mL TOPICAL LIQUID [Derma E Acne Blemish Control Treatment Serum]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control treatment (care as usual, overnight intensive care stay)
Trial: 6344041
Drug: Diflunisal 1000
RxNorm normalized name: Diflunisal
DrugBank: Diflunisal (DB00861)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Diflunisal 1000 mg
Trial: 7665721
Drug: Lornoxicam 16
RxNorm normalized name: Lornoxicam 16 mg prolonged-release oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lornoxicam 16 mg
Trial: 10684124
Drug: Mixed tea
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mixed tea (3 g/day orally and 0.1% smeared on mucosa lesions three times a day for 3 months and 6 months)
Trial: 10549685
Drug: Carbamazepine (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carbamazepine (300 mg/day)
Trial: 2617212
Drug: Erythromycin acistrate
RxNorm normalized name: Erythromycin
DrugBank: Erythromycin (DB00199)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Erythromycin acistrate 500 mg t.i.d. for 1 week
Trial: 2617212
Drug: Erythromycin stearate
RxNorm normalized name: Erythromycin Stearate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Erythromycin stearate 500 mg t.i.d. for 1 week
Trial: 31774037
Drug: Vorapaxar 2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vorapaxar 2.5 mg per day for 12 weeks
Trial: 31273244
Drug: Intranasal AVP
RxNorm normalized name: influenza A virus (H1N1) antigen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intranasal AVP
Trial: 25689743
Drug: High-fiber AXOS
RxNorm normalized name: fiber
DrugBank: Calcium polycarbophil (DB14684)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-fiber AXOS (15 g)
Trial: 25689743
Drug: High-fiber FLAX
RxNorm normalized name: fiber
DrugBank: Calcium polycarbophil (DB14684)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-fiber FLAX (15 g)
Trial: 25689743
Drug: Low-fiber (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-fiber (4 g)
Trial: 23751992
Drug: 2 L
RxNorm normalized name: H-2 locus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 L PEG plus ascorbic acid (PEG+Asc)
Trial: 23751992
Drug: 4 L
RxNorm normalized name: PEG-4 laurate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 L PEG plus simethicon (PEG+Sim)
Trial: 22126115
Drug: Mindfulness-Based Cognitive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mindfulness-Based Cognitive Therapy (MBCT) program plus usual care
Trial: 19447387
Drug: Non-EPA treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-EPA treatment
Trial: 17431702
Drug: Albumin therapy
RxNorm normalized name: Albumin Aggregated
DrugBank: Albumin Aggregated (DB14230)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Albumin therapy (40 g or 80 g within 24 h from symptom onset)
Trial: 9273030
Drug: Transconjunctival injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transconjunctival injection
Trial: 9273030
Drug: Transcutaneous injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transcutaneous injection
Trial: 3119785
Drug: 18 or
RxNorm normalized name: Panlor Reformulated Jan 2018 Oral Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 18 or 24 Gy of radiation therapy (RT) to craniospinal plus abdominal RT including the ovaries
Trial: 3119785
Drug: 18 or
RxNorm normalized name: Panlor Reformulated Jan 2018 Oral Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 18 or 24 Gy of radiation therapy (RT) to craniospinal RT
Trial: 3119785
Drug: 18 or
RxNorm normalized name: Panlor Reformulated Jan 2018 Oral Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 18 or 24 Gy of radiation therapy (RT) to cranial RT
Trial: 28774856
Drug: Modafinil 3.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Modafinil 3.2 mg/kg (in mice)
Trial: 28774856
Drug: Modafinil 10
RxNorm normalized name: modafinil 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Modafinil 10 mg/kg (in mice)
Trial: 28774856
Drug: Modafinil 32
RxNorm normalized name: Modafinil
DrugBank: Modafinil (DB00745)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Modafinil 32 mg/kg (in mice)
Trial: 22189151
Drug: Polyalkylamide gel
RxNorm normalized name: polyacrylamide (10000 MW)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Polyalkylamide gel (PAIG) treatment
Trial: 22189151
Drug: Delayed PAIG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Delayed PAIG injections (12 weeks later)
Trial: 9758086
Drug: Nifedipine GITS
RxNorm normalized name: Nifedipine
DrugBank: Nifedipine (DB01115)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nifedipine GITS alone or in combination with HCTZ
Trial: 3377211
Drug: Continuous epidural
RxNorm normalized name: ACCU-BLOC PERIFIX CONTINUOUS EPIDURAL ANESTHESIA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous epidural infusion of fentanyl 10 micrograms/ml with bupivacaine 0.1%
Trial: 3377211
Drug: Continuous epidural
RxNorm normalized name: ACCU-BLOC PERIFIX CONTINUOUS EPIDURAL ANESTHESIA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous epidural infusion of morphine 0.1 mg/ml with bupivacaine 0.1%
Trial: 29603591
Drug: Vorinostat 430
RxNorm normalized name: Vorinostat
DrugBank: Vorinostat (DB02546)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vorinostat 430 mg/m2/day (days 1-4; 8-11) in combination with isotretinoin 80 mg/m2/dose (days 1-14)
Trial: 29603591
Drug: Vorinostat 430
RxNorm normalized name: Vorinostat
DrugBank: Vorinostat (DB02546)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vorinostat 430 mg/m2/day (days 1-4; 8-11)
Trial: 26503614
Drug: Oral immunotherapy
RxNorm normalized name: Adoptive immunotherapy agent CTL019
DrugBank: Tisagenlecleucel (DB13881)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral immunotherapy (OIT) for cows' milk allergy
Trial: 25973439
Drug: apremilast 20
RxNorm normalized name: apremilast 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: apremilast 20 mg BID
Trial: 25973439
Drug: apremilast 30
RxNorm normalized name: apremilast 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: apremilast 30 mg BID
Trial: 20944074
Drug: EZG (RTG)
RxNorm normalized name: EZG
DrugBank: Ezogabine (DB04953)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: EZG (RTG) 600 mg/d
Trial: 20944074
Drug: EZG (RTG)
RxNorm normalized name: EZG
DrugBank: Ezogabine (DB04953)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: EZG (RTG) 900 mg/d
Trial: 12823389
Drug: Drotaverine hydrochloride
RxNorm normalized name: drotaverine hydrochloride
DrugBank: Drotaverine (DB06751)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drotaverine hydrochloride (80 mg, intravenous, with possible repeat dose)
Trial: 7851466
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of tropisetron plus ketanserin
Trial: 2647123
Drug: Nifedipine (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nifedipine (20 mg to 60 mg daily)
Trial: 23351836
Drug: Internet-based aftercare
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Internet-based aftercare with weekly writing tasks and therapeutic feedback, a patient forum, a self-test and relaxation exercises (n = 400)
Trial: 21288539
Drug: C‐AT (computer-assisted
FDA approved: no
EMA approved: no
PMDA approved: no
Description: C‐AT (computer-assisted treatment program, My Sentence Builder)
Trial: 21288539
Drug: nC‐AT (non
FDA approved: no
EMA approved: no
PMDA approved: no
Description: nC‐AT (non computer-assisted treatment, conventional language stimulation procedures)
Trial: 19853105
Drug: Alternative topical
RxNorm normalized name: yellow fever virus strain 17D-204 live antigen
DrugBank: Yellow fever vaccine (DB10805)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alternative topical hemostatic agents
Trial: 17368254
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (without oxytocin infusion)
Trial: 15222727
Drug: Test formulation
RxNorm normalized name: mumps skin test antigen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Test formulation of ciprofloxacin 750 mg (supplied by Dr. August Wolff GmbH and Co., Germany)
Trial: 10026839
Drug: SR 49059
RxNorm normalized name: SR 121463
DrugBank: SR 121463 (DB05455)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SR 49059 1 mg
Trial: 10026839
Drug: SR 49059
RxNorm normalized name: SR 121463
DrugBank: SR 121463 (DB05455)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SR 49059 10 mg
Trial: 10026839
Drug: SR 49059
RxNorm normalized name: SR 121463
DrugBank: SR 121463 (DB05455)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SR 49059 100 mg
Trial: 10026839
Drug: SR 49059
RxNorm normalized name: SR 121463
DrugBank: SR 121463 (DB05455)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SR 49059 300 mg
Trial: 10026839
Drug: SR 49059
RxNorm normalized name: SR 121463
DrugBank: SR 121463 (DB05455)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SR 49059 600 mg
Trial: 15889952
Drug: Intramuscular haloperidol
RxNorm normalized name: Haloperidol
DrugBank: Haloperidol (DB00502)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intramuscular haloperidol decanoate
Trial: 2106534
Drug: Haloperidol in
RxNorm normalized name: Haloperidol Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Haloperidol in combination with carbamazepine
Trial: 2106534
Drug: Haloperidol in
RxNorm normalized name: Haloperidol Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Haloperidol in combination with lithium carbonate
Trial: 28361441
Drug: Telephone-based cognitive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Telephone-based cognitive behavioral therapy (T-CBT)
Trial: 29077152
Drug: High molecular
RxNorm normalized name: dextran, high molecular weight
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High molecular weight Sodium Hyaluronate (3%) plus saline solution (NaCl 0.9%) twice a day for 30 days
Trial: 29077152
Drug: Saline solution
RxNorm normalized name: Unisol 4 Saline Solution
DrugBank: Sodium chloride (DB09153)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Saline solution twice a day for 30 days
Trial: 13678770
Drug: Alendronate 2.5-10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alendronate 2.5-10 mg per day for 2 years
Trial: 13678770
Drug: Alendronate 20
RxNorm normalized name: alendronate
DrugBank: Alendronic acid (DB00630)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Alendronate 20 mg per day for 2 years
Trial: 10515039
Drug: Alisate (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alisate (300 mg, 1 tablet twice a day for 4-6 weeks)
Trial: 10515039
Drug: Conventional antirheumatic
RxNorm normalized name: ANTIRHEUMATICS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional antirheumatic therapy
Trial: 26189154
Drug: Combination intervention
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination intervention strategy (CIS)
Trial: 25835622
Drug: Intermediate Dose
RxNorm normalized name: Prevotella intermedia
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intermediate Dose (ID) - 76.8Gy < BED 10 < 100.8 Gy (e.g., >64 Gy/32 fr and <74 Gy/37 fr)
Trial: 25835622
Drug: Standard Dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard Dose (SD) - 72Gy ≤ BED 10 ≤ 76.8 Gy (e.g., 60‐64 Gy/30‐32 fractions)
Trial: 25835622
Drug: Intermediate Dose
RxNorm normalized name: Prevotella intermedia
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intermediate Dose (ID)
Trial: 19536605
Drug: Continued pharmacological
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continued pharmacological treatment
Trial: 16776781
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (prescription and voucher after 3 months)
Trial: 11579891
Drug: Sulfadoxine-pyrimethamine (SP)
RxNorm normalized name: pyrimethamine / sulfadoxine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sulfadoxine-pyrimethamine (SP) - dosage: pyrimethamine 1.25 mg/kg and sulfadoxine 25 mg/kg, single dose
Trial: 11579891
Drug: Proguanil (PG)
DrugBank: Proguanil (DB01131)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Proguanil (PG) plus Dapsone (DS) - dosage: PG 10 mg/kg and DS 2.5 mg/kg each day for 3 days
Trial: 9443139
Drug: Massage therapy
RxNorm normalized name: CAMPHOR (SYNTHETIC) 30 g in 1 mL / MENTHOL 40 g in 1 mL TOPICAL OIL [CBDMEDIC MASSAGE THERAPY]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Massage therapy in addition to coaching in breathing from partners during labor
Trial: 8098885
Drug: Nootropic piracetam
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nootropic piracetam (daily dosage 1.2 g)
Trial: 3755554
Drug: Brufen 200
RxNorm normalized name: Brufen 200 MG Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Brufen 200 mg tablets
Trial: 3755554
Drug: Inza 200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inza 200 mg and 400 mg tablets
Trial: 31805385
Drug: Preoperative fascia
RxNorm normalized name: povidone-iodine
DrugBank: Povidone-iodine (DB06812)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Preoperative fascia iliaca block (35-40 mL ropivacaine 0.35%)
Trial: 19369319
Drug: haloperidol (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: haloperidol (1 to 4 mg/day)
Trial: 19369319
Drug: amisulpride (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: amisulpride (200 to 800 mg/day)
Trial: 19369319
Drug: olanzapine (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: olanzapine (5 to 20 mg/day)
Trial: 19369319
Drug: quetiapine (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: quetiapine (200 to 750 mg/day)
Trial: 19369319
Drug: ziprasidone (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ziprasidone (40 to 160 mg/day)
Trial: 15253956
Drug: Testosterone replacement
RxNorm normalized name: Testosterone
DrugBank: (1,2,6,7-3H)Testosterone (DB14093)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Testosterone replacement therapy (Sustanon 100)
Trial: 11849859
Drug: Probucol (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Probucol (500 mg/day, n = 82)
Trial: 11849859
Drug: Pravastatin (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pravastatin (10 mg/day, n = 83)
Trial: 9688105
Drug: Sibutramine (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sibutramine (10 mg once daily)
Trial: 4574642
Drug: Paracetamol with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paracetamol with tepid sponging
Trial: 21762493
Drug: Zhizhu pills
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zhizhu pills containing immature orange fruit of Citrus aurantium L. (IFCA), 6 g each time, 3 times a day for 4 weeks
Trial: 21762493
Drug: Zhizhu pills
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zhizhu pills containing immature orange fruit of Citrus sinensis Osbeck (IFCS), 6 g each time, 3 times a day for 4 weeks
Trial: 1502484
Drug: Cisapride 10
RxNorm normalized name: cisapride 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cisapride 10 mg tablets three times daily for 4 weeks
Trial: 6497518
Drug: Hydrochlorothiazide therapy
RxNorm normalized name: Hydrochlorothiazide
DrugBank: Hydrochlorothiazide (DB00999)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hydrochlorothiazide therapy (2 weeks)
Trial: 6497518
Drug: Hydrochlorothiazide therapy
RxNorm normalized name: Hydrochlorothiazide
DrugBank: Hydrochlorothiazide (DB00999)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hydrochlorothiazide therapy (4 weeks)
Trial: 28968031
Drug: Standard medical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard medical therapy + ozone therapy (subgroup 1a: intravenous ozonized physiological solution, n=28)
Trial: 28968031
Drug: Standard medical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard medical therapy + ozone therapy (subgroup 1b: major ozonized autohemotherapy, n=29)
Trial: 28968031
Drug: Comprehensive treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Comprehensive treatment including gravitational therapy + medical ozone (subgroup 2a: standard medical therapy + ozonized physiological solution + gravitational therapy, n=31)
Trial: 28968031
Drug: Comprehensive treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Comprehensive treatment including gravitational therapy + medical ozone (subgroup 2b: standard medical therapy + major ozonized autohemotherapy + gravitational therapy, n=31)
Trial: 28968031
Drug: Standard medical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard medical therapy only (control group, n=20)
Trial: 26269002
Drug: Pioglitazone (15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pioglitazone (15 mg or 30 mg)
Trial: 17264187
Drug: Sibutramine (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sibutramine (10 mg)
Trial: 19855170
Drug: HPV 6/11/16/18
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HPV 6/11/16/18 vaccine
Trial: 16267842
Drug: Bromocriptine 25
RxNorm normalized name: bromocriptine 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bromocriptine 25 mg/day
Trial: 14720615
Drug: 3 mg
RxNorm normalized name: boron 3 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 mg drospirenone/30 microg ethinylestradiol
Trial: 10866253
Drug: Bone Injection
RxNorm normalized name: bone meal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bone Injection Gun
Trial: 4045435
Drug: 5-micrograms recombinant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5-micrograms recombinant hepatitis B vaccine
Trial: 4045435
Drug: 10-micrograms recombinant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10-micrograms recombinant hepatitis B vaccine